Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2000 | 03-2000 | 01-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,135 | N/A | -8,816 | -5,170 | -6,390 |
| Depreciation Amortization | 1,093 | 720 | 720 | 360 | 880 |
| Accounts payable and accrued liabilities | -1,872 | N/A | -710 | N/A | N/A |
| Other Working Capital | -592 | -3,650 | -3,656 | -2,110 | -2,360 |
| Other Operating Activity | 2,020 | 90 | 809 | 40 | 140 |
| Operating Cash Flow | $-14,486 | $-2,840 | $-11,653 | $-6,880 | $-7,730 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,676 | N/A | -4,860 | N/A | N/A |
| PPE Investments | -2,174 | -1,060 | -1,066 | -340 | -1,910 |
| Other Investing Activity | 0 | -4,860 | 0 | -3,990 | 1,900 |
| Investing Cash Flow | $-4,850 | $-5,920 | $-5,926 | $-4,330 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 116,121 | N/A | N/A | N/A | N/A |
| Debt Repayment | -277 | N/A | -184 | N/A | N/A |
| Common Stock Issued | 47,626 | N/A | 46,548 | N/A | N/A |
| Other Financing Activity | 392 | 46,360 | 288 | 240 | 480 |
| Financing Cash Flow | $163,862 | $46,360 | $46,652 | $240 | $480 |
| Beginning Cash Position | 24,238 | N/A | 24,238 | 24,230 | 31,500 |
| End Cash Position | 168,764 | N/A | 53,311 | 13,260 | 24,230 |
| Net Cash Flow | $144,526 | $37,600 | $29,073 | $-10,970 | $-7,270 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,486 | -2,840 | -11,653 | -6,880 | -7,730 |
| Capital Expenditure | -2,174 | N/A | -1,066 | N/A | N/A |
| Free Cash Flow | -16,660 | -2,840 | -12,719 | -6,880 | -7,730 |